Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.3410
-0.0277 (-7.51%)
At close: Apr 6, 2026, 4:00 PM EDT
0.3479
+0.0069 (2.02%)
After-hours: Apr 6, 2026, 6:01 PM EDT
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $12.37 million as of April 6, 2026. Its market cap has decreased by -39.72% in one year.
Market Cap
12.37M
Enterprise Value
14.22M
1-Year Change
-39.72%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $12.37M, a decrease of -90.66%. That is a compound annual growth rate of -83.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 13.38M | -61.91% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 14.48M |
| GT Biopharma | 14.18M |
| IN8bio | 14.18M |
| Biodexa Pharmaceuticals | 14.15M |
| OSR Holdings | 14.11M |
| Genprex | 13.93M |
| BioCardia | 13.13M |
| Traws Pharma | 13.11M |